O
IPXL
OrbiMed’s Impax Laboratories, Inc. IPXL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | – | Sell |
-3,787,500
| Closed | -$89.8M | – | 141 |
|
|
2016
Q3 | $89.8M | Sell |
3,787,500
-2,099,200
| -36% | -$49.8M | 1.02% | 36 |
|
|
2016
Q2 | $170M | Sell |
5,886,700
-889,400
| -13% | -$25.6M | 1.77% | 18 |
|
|
2016
Q1 | $217M | Buy |
6,776,100
+112,000
| +2% | +$3.59M | 2.28% | 11 |
|
|
2015
Q4 | $285M | Hold |
6,664,100
| – | – | 2.58% | 12 |
|
|
2015
Q3 | $235M | Sell |
6,664,100
-75,100
| -1% | -$2.64M | 2.37% | 11 |
|
|
2015
Q2 | $309M | Buy |
6,739,200
+61,200
| +0.9% | +$2.81M | 2.59% | 12 |
|
|
2015
Q1 | $313M | Hold |
6,678,000
| – | – | 2.67% | 11 |
|
|
2014
Q4 | $212M | Buy |
6,678,000
+272,800
| +4% | +$8.64M | 2.02% | 16 |
|
|
2014
Q3 | $152M | Buy |
6,405,200
+989,600
| +18% | +$23.5M | 1.59% | 24 |
|
|
2014
Q2 | $162M | Buy |
5,415,600
+70,000
| +1% | +$2.1M | 1.91% | 21 |
|
|
2014
Q1 | $141M | Buy |
5,345,600
+1,108,000
| +26% | +$29.3M | 1.74% | 23 |
|
|
2013
Q4 | $107M | Buy |
4,237,600
+951,900
| +29% | +$23.9M | 1.57% | 23 |
|
|
2013
Q3 | $67.3M | Buy |
3,285,700
+25,100
| +0.8% | +$514K | 1.2% | 27 |
|
|
2013
Q2 | $65M | Buy |
+3,260,600
| New | +$65M | 1.38% | 28 |
|